Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
MDVN > SEC Filings for MDVN > Form 8-K on 26-Apr-2013All Recent SEC Filings

Show all filings for MEDIVATION, INC. | Request a Trial to NEW EDGAR Online Pro

Form 8-K for MEDIVATION, INC.


26-Apr-2013

Other Events, Financial Statements and Exhibits


Item 8.01 Other Events.

On April 26, 2013, Medivation, Inc. (the "Company") and Astellas Pharma Inc. ("Astellas"), the Company's collaboration partner, issued a joined press release announcing that Astellas Pharma Europe Ltd., the European Headquarters of Astellas, and the Company have received a positive opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use, recommending European Commission approval for XTANDIŽ(enzalutamide) capsules for the treatment of adult men with metastatic castration-resistant prostate cancer whose disease has progressed on or after docetaxel therapy. A copy of the press release is attached hereto as Exhibit 99.1 and is also incorporated herein by reference.



Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

99.1    Joint press release dated April 26, 2013, announcing positive opinion from
        the European Medicines Agency's Committee for Medicinal Products for Human
        Use recommending XTANDI(enzalutamide) in advanced prostate cancer.


  Add MDVN to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for MDVN - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.